相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
Nicole Concin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma
Takafumi Watanabe et al.
TRANSLATIONAL ONCOLOGY (2021)
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
Francois Bertucci et al.
GENOME MEDICINE (2021)
Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer
Ting-Tai Yen et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2020)
Proteogenomic Characterization of Endometrial Carcinoma
Yongchao Dou et al.
CELL (2020)
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers
Francois Bertucci et al.
MOLECULAR ONCOLOGY (2020)
PTEN mutation: A potential prognostic factor associated with immune infiltration in endometrial carcinoma
Ye Tao et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Molecular basis of distinct oestrogen responses in endometrial and breast cancer
Eva Baxter et al.
ENDOCRINE-RELATED CANCER (2019)
Genomic characterization of metastatic breast cancers
Francois Bertucci et al.
NATURE (2019)
A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases
Marguerite Tyran et al.
CANCERS (2019)
Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review
Willem Jan van Weelden et al.
FRONTIERS IN ONCOLOGY (2019)
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer
Zannel Blanchard et al.
GENOME RESEARCH (2019)
Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Endocrine therapy in endometrial cancer: An old dog with new tricks
Katarzyna J. Jerzak et al.
GYNECOLOGIC ONCOLOGY (2019)
Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review
Antonio Travaglino et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
A Proposal for a Classification for Recurrent Endometrial Cancer Analysis of a French Multicenter Database From the FRANCOGYN Study Group
Alexandre Bricou et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study
Jung-Min Lee et al.
LANCET ONCOLOGY (2018)
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo A. Knijnenburg et al.
CELL REPORTS (2018)
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E. Soumerai et al.
CLINICAL CANCER RESEARCH (2018)
Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis
Josee-Lyne Ethier et al.
GYNECOLOGIC ONCOLOGY (2017)
Endometrial Cancers With Activating KRas Mutations Have Activated Estrogen Signaling and Paradoxical Response to MEK Inhibition
Kari L. Ring et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer
Patricia Pautier et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Confirmation of ProMisE: A Simple, Genomics-Based Clinical Classifier for Endometrial Cancer
Aline Talhouk et al.
CANCER (2017)
Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer
Floor J. Backes et al.
GYNECOLOGIC ONCOLOGY (2016)
Oral Progestin Treatment for Early-Stage Endometrial Cancer A Systematic Review and Meta-analysis
Yun Qin et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
William J. Gibson et al.
NATURE GENETICS (2016)
Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
Yiying Wang et al.
ONCOTARGET (2016)
Comparative genomic analysis of primary tumors and metastases in breast cancer
Francois Bertucci et al.
ONCOTARGET (2016)
Recurrent hormone-binding domain truncated ESR1 amplifications in primary endometrial cancers suggest their implication in hormone independent growth
Frederik Holst et al.
SCIENTIFIC REPORTS (2016)
Racial/Ethnic Disparities in Genomic Sequencing
Daniel E. Spratt et al.
JAMA ONCOLOGY (2016)
A clinically applicable molecular-based classification for endometrial cancers
A. Talhouk et al.
BRITISH JOURNAL OF CANCER (2015)
Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study
Paul J. Goodfellow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: A gynecologic oncology group study
Gini F. Fleming et al.
GYNECOLOGIC ONCOLOGY (2014)
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
Jonathan Ledermann et al.
LANCET ONCOLOGY (2014)
Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration
Helga Thorvaldsdottir et al.
BRIEFINGS IN BIOINFORMATICS (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Luminal breast cancer: from biology to treatment
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
V. Abkevich et al.
BRITISH JOURNAL OF CANCER (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group
Amit M. Oza et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Multivariate survival analysis of the patients with recurrent endometrial cancer
Tetsuji Odagiri et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Adjuvant progestagens for endometrial cancer
Pierre P. L. Martin-Hirsch et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
Kai Ye et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance
Xiaojun Chen et al.
MODERN PATHOLOGY (2009)
BRCAness Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations
David S. P. Tan et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer
Koji Yamazawa et al.
HUMAN REPRODUCTION (2007)
分享论文
